The completion of the human genome project has paved the way for major advances in our understanding of human genetic disease and the pathogenesis of cancer. Nevertheless, these advances have also revealed that genetics is only part of the story and there is increasing recognition that epigenetics will be critical for understanding human disease and the practice of genomic medicine. The University of Birmingham is home to several research groups focussing on epigenetic research, as well as clinicians who use “epigenetic drugs” in their daily practice. This microcredential will draw on world-leading local scientists to provide expert coverage of this fascinating topic.
Dr Maarten Hoogenkamp (Leukaemia & Lymphoma Research Bennett Fellow, Institute of Cancer and Genomic Sciences)
Dr Marco Saponaro (Birmingham Fellow, Institute of Cancer and Genomic Sciences)
This microcredential can be taken as a stand-alone assessed or non-assessed course.
You should have a good honours degree in a life sciences subject, although we will consider applicants with alternative qualifications and professional experience within the health service or other relevant background. You should take the Fundamentals in Human Genetics and Genomics first, or be able to show you have equivalent knowledge and understanding to enable you to benefit from this microcredential.
Please contact the Programme Administrator for further information at firstname.lastname@example.org